Weekly event: Innovation boosters
Book your innovation booster
Despite the postponing of our “We are HTRIC kick-off event” to 17 June 2022, we wish to keep the energy going towards new collaborations and innovations in health technology. Therefore, HTRIC is organising a series of innovation boosters.
Every Friday from 4 March till 10 June 2022, people are welcome at the HTRIC headquarters for a 2.5-hour meeting with lunch. Each week we will have a different health technology related theme. Meetings will start with a presentation by the main speaker(s), followed by group discussions.
Join our innovation boosters to connect with fellow MedTech experts and professionals, share your knowledge and exchange ideas. Each booster has place for 30-60 people, so please sign up on time.
- Dates: Fridays from 4 March till 10 June 2022 (with the exception of public and school holidays)
- Time: 11.00 a.m. till 1.30 p.m. (including lunch)
- Place: Innovation Center Chemistry & Engineering (Blauwborgje 31, Zernike Campus, Groningen)
Find the schedule and registration form below.
Innovation Booster on ‘Safe by Design’ of medical products
Have you ever wondered how medical products are designed/planned so they can be safely applied in patient care? Do you want to learn how companies and researchers make use of safe by design for the development of medical products or patient care? To find out the answers to these and other questions, join us on March 4th for the very first HTRIC Innovation Booster with amazing speakers from companies and researchers discussing how safe by design is applied in their businesses/research for medical product development or patient care.
- 11.00 – 11.10 a.m. – Introduction
- Hélder & Jeroen
- 11.10 – 11.30 a.m. – RIVM
- Jaco Westra, strategic advisor
- 11.30 – 11.50 a.m. – Ivy Medical
- Melcher Frankema, CEO
- 11.50 – 12.10 a.m. – 3D Lab
- Max Witjes, Professor of Head & Neck Oncology, UMCG
- Joep Kraeima, Technical Physician Specialist dpt. Oral and Maxillofacial, UMCG
- 12.10 – 12.40 – ‘Round table’
- Discussion between presenters and audience
- 12.40 a.m. – 1.00 p.m. – Announcement
- The very first 4 PhD HTRIC project winners are announced, including short presentations of the selected projects
- 1.00 – 2.00 p.m. – Lunch
- Including networking
Sensing and monitoring: innovations transforming healthcare at hospitals and home
Could wearable sensor technology innovations be the new standard of human movement monitoring at home and hospitals? Could wearable sensor technology assist a healthy lifestyle at work and home? Could Biomedical sensors and devices automate measurements at hospitals, reduce nurse workload and improve home care? Join our innovation booster series which discusses these questions through a series of talks, pitches and group discussions by scientists and entrepreneurs.
- 11.00 a.m. – Opening
- Healthy lifestyles supported by smart monitoring sensors – prof. dr. Claudine Lamoth
- Wearable electronic sensors for monitoring physical function and movements – dr. Ajay Kottapalli
- Theme: Movement and physical funtion: sensing and monitoring
- SMOVE project – Natasha Maurits
- Smart Implants – Charissa Roossien
- Healthy worker and sensor monitoring – Elisabeth Wilhelm
- Start-up pitch – Behesta Doestzada
- 12.05 – 12.15 a.m. – break
- Theme: Biomedical devices and clinical sensors
- Optimising shoe parameters based on advanced biomechanical gait analysis – Juha Hijmans, UMCG
- Integration of Urinary sodium and flow in daily practice – Acute Heart Failure – Kevin Damman (Cardiologist), UMCG, (virtual)
- Start-up pitch “Biomedical flow management in hospital and home care” – Amar Kamat (Sencilia B.V.)
- Introduction to case study break-out sessions (3 teams)
- 1.10 – 1.30 p.m. – Discussion of break-out sessions
- Team representative will present their vision
- 1.30 – 2.30 p.m. – Lunch and networking
Stepping into the future with a new generation of bionic legs
In The Netherlands, more than 3000 individuals are annually confronted with lower-limb amputation, mainly as the consequence of peripheral vascular disease or diabetes and, to a lesser extent, as a consequence of trauma or cancer. Lower-limb amputation has large impact on the patients’ mobility, participation, and quality of life.
In the innovation booster on Artificial Limbs, we want to discuss the patients’ needs, the current clinical challenges and engineering solutions, and we want to share our outlook to the future.
If you are a lower-limb amputee, OR if you want to contribute as a scientists/clinician/orthopedics expert, OR you are simply curious about it, join our innovation booster: “Stepping into the future with a new generation of bionic legs”.
See you there!
- 11.00 a.m. – Opening
- prof. dr. Raffaella Carloni, prof. dr. Han Houdijk & dr. Aline H. Vrieling
- 11.05 a.m. – Lower limb amputation and rehabilitation
- Charlotte E. Bosman, UMCG
- 11.20 a.m. – Muscoloskeletal mechanics and energetics in people with lower-limb amputation
- prof. dr. Han Houdijk, UMCG
- 11.35 a.m. – Mechatronic development of lower-limb prostheses
- prof. dr. Raffaella Carloni, RUG/FSE
- 11.50 a.m. – Prosthetic alignment
- Niels Jonkergouw, UMCG
- 12.05 a.m. – Orthopedic assistive technology
- Jeroen Olsman, OIM Orthopedie
- 12.20 a.m. – State-of-the-art of lower limb prostheses
- Mr. Peter Slijkhuis, Össur
- 12.40 a.m. – Discussion and closing
- prof. dr. Raffaella Carloni, prof. dr. Han Houdijk & dr. Aline H. Vrieling
- 1.00 p.m. – 1.30 p.m. – Lunch
Great idea! Now what?
You have a great life science or medtech idea. How do you proceed?
Is there a need and a market for your invention?
IP-protection, patenting, not your cup of tea. Who can help?
Strategy advice, more research and funding. Where do you start?
Contract and licensing negotiations, legal issues. Who to turn to?
These and other questions will be addressed interactively in this Innovation Booster; please sign up if you want to discuss these and your own questions with people who know.
Speakers: Herman Groen & Maarten van Roosmalen (Business Generator Groningen); Nutte van Belzen (CC Diagnostics)
*Please note that the language of this Innovation Booster is Dutch.
Commerciële apps en wearables in de gezondheidszorg en het omgaan met persoonsgegevens en privacy, waar wringt de schoen?
Op dinsdag 29 maart 2022 organiseert de Faculteit Rechtsgeleerdheid, sectie IT-recht, in samenwerking met dHealth, PCH Ecosysteem en DASH een HTRIC Innovation Booster over het gebruik van commerciële apps en wearables in de gezondheidszorg. Aanleiding is de promotie van Trix Mulder op maandag 28 maart as, op haar proefschrift ‘The role of law in protecting personal data generated by health apps and wearables’. Het event start om 10:00 en duurt tot 12:30 met aansluitend een netwerklunch.
In de gezondheidszorg wordt vaak gebruik gemaakt van apps en wearables, en doordat het niet uit kan om deze zelf te ontwikkelen wordt vaak van commerciële IT-middelen gebruik gemaakt. Inmiddels zijn er in de commerciële appstores meer dan 320.000 gezondheids- of wellnessapps te vinden. Hierdoor komt een toenemende hoeveelheid data van burgers en patiënten in het domein van commerciële bedrijven. Daarbij ontstaan er silos van data die onbenut blijven, en is er een gebrek aan overzicht welke data impact kunnen hebben. Dat leidt tot de vraag hoe met het gebruik van deze apps de privacy en het medisch beroepsgeheim gewaarborgd blijven?
Dagvoorzitter Aline Klingenberg
Trix Mulder – over haar onderzoek
Theo Hooghiemstra – over tegenmacht voor mensen die commerciële apps en wearables in de gezondheidszorg willen gebruiken
Jaap-Henk Hoepman – Privacy Preserving Techniques. Op verantwoorde wijze combineren van verspreide onderzoeksdata
Michelle Luxwolda – de ontwikkeling van Sleep in Sync, en het perspectief vanuit praktijk
The North to become a European Centre of Excellence for Nuclear Life Science
In this innovation Booster we invite you to discuss the future of medical isotopes in the North. Both from fabrication and application perspective. What do you think is needed? What would you like to contribute. Let’s think big and put some common goals! (read more)
Speakers: Harrie Buurlage (SHINE Medical – Director Europe); Prof. Sytze Brandenburg (UMCG – Professor in Accelerator Physics); dr. Walter Noordzij (UMCG, Nuclear Medicine)
Every year, more than 1 million people in Europe die of cancer. Ursula von der Leyen – president of the EC – “the fight of those battling cancer is our fight as well”. The EC its ‘Beating Cancer Plan’ focuses on the prevention, treatment and care of cancer. It includes all phases of cancer-development, from prevention to the quality of life of cancer patients and people who have survived cancer.
The Northern Netherlands can and wants to share an essential contribution to the battle against cancer, and in doing so, becoming a recognizable part of this Europe Beating Cancer Plan. The collaboration with the University of Groningen, the Universities of Applied Sciences, the Universitair Medisch Centrum Groningen and SHINE Veendam dreams about becoming a European-acknowledged center of knowledge, innovation and production for nuclear medicine – for all Europeans and far beyond.
How do we further shape this dream on April 8th?
Nuclear medicine and the EC Beating Cancer Plan
New technologies, research and development are the starting point of the EC Beating Cancer Plan. An essential part of the plan is doing more and making better diagnoses. Nuclear diagnoses, as well as nuclear treatments, are recurring elements in the life of a cancer patient. The EC has completely acknowledged the worth of nuclear applications and has made this part of the EC Beating Cancer Plan under the name SAMIRA Action Plan. SAMIRA stands for ‘Strategic Agenda for Medical Ionising Radiation Applications’. The SAMIRA plan guarantees access for European civilians to nuclear medical applications of high quality. The supply security of medical radio-isotopes is one of the goals of this SAMIRA plan. (A medical isotope is the radioactive part of a nuclear medicine).
One of the goals of the SAMIRA plan is the organizing of a European platform for Radio-isotopes. This platform, called European Radioisotopes Valley Initiative (EVRI), will take care of maintaining the European leadership position in the supply of medical radio-isotopes. The EVRI will also take care of the acceleration of development for new radio-isotopes and production methods.
The goal of the innovation booster of April 8th is a first exploration into the possible initiatives in which the RUG, the Universities of Applied Sciences, UMCG and SHINE can collaborate to support the SAMIRA plan and the ERVI initiative. These are initiatives that – just as was meant under the EC Beating Cancer Plan – take into account all phases of cancer development, from prevention to the quality of life for cancer patients and people that have survived cancer.
Games have proven to provide attractive applications in many healthcare areas. Examples can be found e.g. in training games, diagnosing aids and behaviour changes. However, to launch a successful game in the health-care environment, many challenges need to be overcome: a serious approach is required from the start of the game development!
On the 29th of April, NHL Stenden university will host a HTRIC Innovation Booster to provide insights into the complex development process of Games for Health. By using a practical case as an example we will illustrate the steps we take from the exploration of the issue to the design and evaluation of the implementation. By joining this HTRIC Innovation Booster you will experience yourself how the game design process has changed by co-creation with the audience involved.
If you ever thought about developing games for healthcare applications, or work as a healthcare professional and are looking how a serious game can help boosting your daily professional work, then this HTRIC Innovation Booster is for you. Don’t miss out!
When: April 29 2022, from 11.00 a.m. until 1.30 p.m. Lunch included!
Where: HTRIC building, Blauwborgje 31, Zernike Campus, Groningen
MDR and the translation of medical devices to the clinic
…Finally, you are convinced that your innovative product is ready. After months of testing, adapting and asking feedback, you’re about to try your product first time in human or, after having successfully conducted human trials launch your product to the market. Then you are confronted with the hurdle of passing the METC or legislatory bodies and you need to provide data you never thought. Moreover, this is the first time you notice the full impact of some vague term from the past: MDR! It sets you back months and, considering all unexpected costs mounting at your expense, it puts the whole launch at a business risk”. If you recognize or fear such a situation, this booster is definitely for you! On May 13, experts in the field of Medical Device Regulation or the Medical Ethical Review Committee as well as business people who experienced what MDR can do to your business share their experiences and recommendations. This HTRIC MDR Booster aims to make you aware of the MDR regulatory issues and how to turn this in a competitive advantage for your business.
During this booster, Jelmer Sjollema (UMCG, Biomedical Engineering, member METC) will first introduce the background of the MDR, what does it mean, who should adhere, when? Ilona Brouwers (UMCG Innovation Centre) shares her experiences with in-house developed devices and use within the UMCG clinical environment. Gerrit Baarda (ZIUZ) and Rutger Flink (Pulmotec) give their view from a company perspective and what MDR means to doing business in the MedTech segment, and also which other hurdles to pass! We close this MDR booster session with a group discussion how HTRIC could help providing a working platform regarding MDR know-how and best-practices.
We are looking forward to welcoming you on the HTRIC booster “MDR: Innovation killer or booster?” on 13 May 2022, from 11 a.m. until 1:30 pm. Lunch is included. Location is the HTRIC venue at Blauwborghje 31, Zernike Campus Groningen. Please register!
AI and Imaging
On Friday 20 May, DASH, together with HTRIC, DHealth and the AI Hub Noord Nederland, will organise an Innovation Booster on AI in Imaging. In this event, the AI Hub will be introduced, Peter van Ooijen will tell more about the Role of AI in Medical Imaging and you will learn more about Federated Learning on Imaging, Synthetic Imaging Data Generation and the ELSA Tool.
11.00 – 11.10 – Introduction AI Hub Noord Nederland
Yvonne Kooi, AI Hub Noord Nederland
11.10 – 11.30 – Role of AI in Medical Imaging
Peter van Ooijen, DASH/UMCG
11.30 – 11.50 – Annotation needed! Annotation lab dHealth
To be announced
11.50 – 12.10 – Federated Learning on Imaging
Simon Dalmolen, TNO
12.10 – 12.40 – Synthetic Imaging Data Generation
Mihai Popescu, former Master student FSE/RUG
12.40 – 13.00 – ELSA Tool
To be announced
13.00 – 13.30 – Lunch
The content of this Innovation Booster will soon be announced.